Ahmedin Jemal
Auto-generated profile, based on publicly available information

Ahmedin Jemal

Surveillance, Prevention, and Health Services Research American Cancer Society Atlanta Georgia USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2019 in CA: A Cancer Journal for Clinicians
Verified
Journal Article
Closed access
RSRebecca L. Siegel
Rebecca L. Siegel
KMKimberly D. Miller
Kimberly D. Miller
AJAhmedin Jemal
Ahmedin Jemal

4 January 2018 in CA: A Cancer Journal for Clinicians
Verified
Journal Article
Closed access
PDF file
RSRebecca L. Siegel
Rebecca L. Siegel
KMKimberly D. Miller
Kimberly D. Miller
AJAhmedin Jemal
Ahmedin Jemal

17 June 2011 in CA: A Cancer Journal for Clinicians
Verified
Journal Article
Open access
PDF file
RSRebecca Siegel
Rebecca Siegel
EWElizabeth Ward
Elizabeth Ward
OBOtis Brawley
Otis Brawley
AJAhmedin Jemal
Ahmedin Jemal
CA: A Cancer Journal for Clinicians publishes information about the prevention, early detection, and treatment of cancer, as well as nutrition, palliative care, survivorship, and additional topics of interest related to cancer care.

1 August 2010 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
AJAhmedin Jemal
Ahmedin Jemal
MCMelissa M. Center
Melissa M. Center
CDCarol DeSantis
Carol DeSantis
EWElizabeth M. Ward
Elizabeth M. Ward
While incidence and mortality rates for most cancers (including lung, colorectum, female breast, and prostate) are decreasing in the United States and many other western countries, they are increasing in several less developed and economically transitioning countries because of adoption of unhealthy western lifestyles such as smoking and physical inactivity and consumption of calorie-dense food. Indeed, the rates for lung and colon cancers in a few of these countries have already surpassed those in the United States and other western countries. Most developing countries also continue to be disproportionately affected by cancers related to infectious agents, such as cervix, liver, and stomach cancers. The proportion of new cancer cases diagnosed in less developed countries is projected to increase from about 56% of the world total in 2008 to more than 60% in 2030 because of the increasing trends in cancer rates and expected increases in life expectancy and growth of the population. In this review, we describe these changing global incidence and mortality patterns for select common cancers and the opportunities for cancer prevention in developing countries. Cancer Epidemiol Biomarkers Prev; 19(8); 1893–907. ©2010 AACR.

15 December 2015
Verified
Book Chapter
Closed access
PDF file
LTLindsey A. Torre
Lindsey A. Torre
RSRebecca L. Siegel
Rebecca L. Siegel
AJAhmedin Jemal
Ahmedin Jemal

21 November 2017 in CA: A Cancer Journal for Clinicians
Verified
Journal Article
Open access
PDF file
FIFarhad Islami
Farhad Islami
ASAnn Goding Sauer
Ann Goding Sauer
KMKimberly D. Miller
Kimberly D. Miller
RSRebecca L. Siegel
Rebecca L. Siegel
SFStacey A. Fedewa
Stacey A. Fedewa
AJAhmedin Jemal
Ahmedin Jemal
Contemporary information on the fraction of cancers that potentially could be prevented is useful for priority setting in cancer prevention and control. Herein, the authors estimate the proportion and number of invasive cancer cases and deaths, overall (excluding nonmelanoma skin cancers) and for 26 cancer types, in adults aged 30 years and older in the United States in 2014, that were attributable to major, potentially modifiable exposures (cigarette smoking; secondhand smoke; excess body weight; alcohol intake; consumption of red and processed meat; low consumption of fruits/vegetables, dietary fiber, and dietary calcium; physical inactivity; ultraviolet radiation; and 6 cancer‐associated infections). The numbers of cancer cases were obtained from the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute; the numbers of deaths were obtained from the CDC; risk factor prevalence estimates were obtained from nationally representative surveys; and associated relative risks of cancer were obtained from published, large‐scale pooled analyses or meta‐analyses. In the United States in 2014, an estimated 42.0% of all incident cancers (659,640 of 1570,975 cancers, excluding nonmelanoma skin cancers) and 45.1% of cancer deaths (265,150 of 587,521 deaths) were attributable to evaluated risk factors. Cigarette smoking accounted for the highest proportion of cancer cases (19.0%; 298,970 cases) and deaths (28.8%; 169,180 deaths), followed by excess body weight (7.8% and 6.5%, respectively) and alcohol intake (5.6% and 4.0%, respectively). Lung cancer had the highest number of cancers (184,970 cases) and deaths (132,960 deaths) attributable to evaluated risk factors, followed by colorectal cancer (76,910 cases and 28,290 deaths). These results, however, may underestimate the overall proportion of cancers attributable to modifiable factors, because the impact of all established risk factors could not be quantified, and many likely modifiable risk factors are not yet firmly established as causal. Nevertheless, these findings underscore the vast potential for reducing cancer morbidity and mortality through broad and equitable implementation of known preventive measures. CA Cancer J Clin 2018;68:31‐54 . © 2017 American Cancer Society .